Coppell Advisory Solutions LLC Evogene Ltd. Transaction History

Coppell Advisory Solutions LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.47 - $0.88 $15 - $29	-33 Reduced 55.0%	27 $23,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.41 $19 - $46	33 Added 122.22%	60 $42,000
Q2 2023 Aug 17, 2023	BUY	$0.56 - $1.2 $15 - $32	27 New	27 $30,000
Q1 2023 May 19, 2023	SELL	$0.59 - $0.86 $35 - $51	-60 Closed	0 $0
Q4 2022 May 19, 2023	BUY	$0.61 - $8.13 $36 - $487	60 New	60 $42,000

117K

Ticker EVGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,202,000
Market Cap $61.4M
Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

Stay updated on Coppell Advisory Solutions LLC with notifications on news.